More Patrys Limited news
Patrys LimitedASX: PAB

Europe grants patent for Deoxymab 3E10

Jul 17, 2019 at 12:04 AM EDT · Issued by Patrys Limited

Filed with ASX · Jul 17, 2019 at 12:04 AM EDT

On 6ix: 6ix.com/news/europe-grants-patent-for-deoxymab-3e10

Patrys Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Patrys Limited on 6ix

Story so far

  • China and Japan both grant patents for Deoxymab 3E10Jul 3, 2018
  • Patrys Deoxymab 3E10 patent granted in the U.S.Jul 12, 2017
  • PAB Licences Deoxymab 3E10 - nanoparticle IP from YaleJun 13, 2017

Earlier from Patrys

  • PAT-DX1 Reduces Brain Metastases, Enhances Radiation TherapyMay 29, 2019
  • Appendix 4C - Quarterly - 31 March 2019Apr 23, 2019
  • Market UpdateMar 29, 2019
  • Appendix 4D - Half Year Accounts - 31 December 2018Feb 20, 2019
  • Appendix 4C - Quarterly - 31 December 2018Jan 30, 2019

Later from Patrys

  • PAT-DX1 significantly improves survival in aggressive GBMJul 21, 2019
  • Appendix 4C - Quarterly - 30 June 2019Jul 29, 2019
  • Appendix 4E and 2019 Annual ReportAug 22, 2019
  • Appendix 4C - Quarterly - 30 September 2019Oct 28, 2019
  • Appendix 4C - Quarterly - 31 December 2019Jan 29, 2020
All Patrys news releases↗

Follow Patrys into a list and get an email when it puts out news.

Follow Patrys
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer